← All stocks

MEDIFAST INC

MED Net buying

CIK 0000910329 #4193 in the set updated 17 Sep 2026

Bought (1 mo)

$1.42M

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$1.42M

+$1.42M against sales at will

By person

10 insiders · 8 transactions

2.5×

Daniel R. Chard holds only 2.5 times base salary in stock. $2.53M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel R. Chard last reported holding, valued at $12.26, the price Common Stock was last bought or sold at on the open market here, on 26 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Kiai Parsa

Director

$1.42M (8)

—

+$1.42M

58,682

0.5249%

$719.63K

—

Chard Daniel R

Chairman & CEO

—

205,911

1.84%

$2.53M

+250.7%

Maloney James P.

Chief Financial Officer

—

73,033

0.6532%

$895.62K

+273.9%

SCHLACKMAN SCOTT

Director

—

42,229

0.3777%

$517.86K

+193.6%

BROWN JEFFREY J

Director

—

38,578

0.3450%

$473.09K

+114.8%

Thomas Andrea B

Director

—

35,697

0.3193%

$437.76K

+177.8%

Geary Elizabeth A.

Director

—

31,225

0.2793%

$382.92K

+272.7%

Hoer Michael A.

Director

—

26,139

0.2338%

$320.55K

+74.6%

MacKenzie Jonathan Barrett

VP, Finance & CAO

—

20,838

0.1864%

$255.54K

+433.5%

Rose Jeffrey Matthew

Director

—

18,419

0.1647%

$225.88K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 3

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 4 Oct 2016